Treatment of Advanced Chronic Lymphocytic Leukemia (CLL) [with] Fludarabine, Mitoxantrone and Cyclophosphamide With or Without G-CSF [granulocyte colony stimulating factor(s)].

Trial Profile

Treatment of Advanced Chronic Lymphocytic Leukemia (CLL) [with] Fludarabine, Mitoxantrone and Cyclophosphamide With or Without G-CSF [granulocyte colony stimulating factor(s)].

Discontinued
Phase of Trial: Phase III

Latest Information Update: 24 Sep 2016

At a glance

  • Drugs Granulocyte colony-stimulating factors (Primary) ; Cyclophosphamide; Fludarabine; Mitoxantrone
  • Indications Chronic lymphocytic leukaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Sep 2016 Status changed from active, no longer recruiting to discontinued.
    • 24 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top